Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00822523 · ClinicalTrials.gov registry record · NA
Assessment of the Effect of Botulinum Toxin in Extensor Digitorum Brevis Via Strain Gauge and Nerve Conduction Studies
A NA study, sponsored by Loma Linda University.
- Completed
- Registry status
- NA
- Development phase
- 13
- Enrollment target
NCT00822523 is a NA study that has completed, run by Loma Linda University. The registered enrollment target is 13 participants.
The verdict
NCT00822523, a NA study, has completed, sponsored by Loma Linda University.
- COMPLETED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
Study Summary
The purpose of this feasibility study is to determine if temporary weakness of a small foot muscle caused by local injection of botulinum toxin into that muscle can be measured with a strain gauge in addition to the previously known valid measurements via nerve conduction studies and surface electromyogram.
Interventions
- DRUG Saline
- DRUG Botulinum Toxin, Type A
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2009-01 |
| Est. Completion | 2015-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00822523
The ClinicalTrials.gov registry entry for NCT00822523 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Loma Linda University, which has 237 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Saline is the first listed.
NCT00822523 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00822523 about?
NCT00822523 is a clinical study titled "Assessment of the Effect of Botulinum Toxin in Extensor Digitorum Brevis Via Strain Gauge and Nerve Conduction Studies". The purpose of this feasibility study is to determine if temporary weakness of a small foot muscle caused by local injection of botulinum toxin into that muscle can be measured with a strain gauge in addition to the previously known valid measurements via nerve conduction studies and surface electro...
What is the current status of trial NCT00822523?
This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2009-01. Estimated completion is 2015-07.
What interventions are being tested in trial NCT00822523?
The interventions under investigation include: Saline (DRUG), Botulinum Toxin, Type A (DRUG).
Who is sponsoring clinical trial NCT00822523?
This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.